Unlocking the Therapeutic Potential of Complex GPCRs

Orion Biotechnology is a clinical stage company discovering and developing next-generation G Protein-Coupled Receptor (GPCR)-targeted therapeutics for the treatment of cancer and other serious diseases.

Orion’s novel drug modality involves precision engineering ligands of peptide and protein GPCRs to develop analogs with significant advantages over small molecule and antibody approaches

OB-002 Bound to CCR5

CCR5 Inhibitor Program

Orion’s lead compound, OB-002, is a GPCR analog of CCL5 with best-in-class potency and a proven mechanism of action shown to have broad applicability across a range of serious diseases, including Cancer, Infectious Disease and Neuroinflammatory disorders.

Recognized
Leadership

Mark Groper
“Leveraging our Drug Discovery Platform to rapidly and cost effectively generate new therapeutics, Orion is positioned to play a prominent role in bringing the next generation of immunotherapy to patients”
Dr. Oliver Hartley
“I am delighted with how Orion has accelerated the development of OB-002 and I am looking forward to introducing new chemokine analogs into the pipeline”
Dr. Ian McGowan MD, Phd, FRCP
“The development of novel safe and efficacious immunotherapeutic products is the next frontier in cancer therapy – I am delighted that Orion Biotechnology is part of this adventure”
Previous
Next

Orion Adds Industry Leader to Board

Ottawa, Canada, Aug. 31, 2021 (GLOBE NEWSWIRE) — Orion Biotechnology, a clinical stage company that is developing novel G Protein-Coupled Receptor (GPCR)-targeted therapeutics for the treatment of cancer and other

Read More »

Global Headquarters

343 Preston Street

11th floor,

Ottawa, On K1S 1N4

CANADA

+1 343.291.1032

Switzerland

Campus Biotech

Innovation Park

Avenue de Sécheron 15

1202 Genève

SWITZERLAND

Poland

Orion Biotechnology

Life Science Park

UI Bobrzyńskiego 14

30-348 Krakôw

POLAND

contact us

Leave  us a message and we will try to respond by the next business day

ORION Logo Pantone(375x133)

Our Headquarters

343 Preston Street

11th floor,

Ottawa, ON K1S 1N4

CANADA

info@orionbiotechnology.com

+1 343.291.1032

This website uses cookies to ensure you get the best experience on our site.  By using this website, you agree to our use of cookies.

contact us

Leave  us a message and we will try to respond by the next business day

ORION Logo Pantone(375x133)

Our Headquarters

343 Preston Street

11th floor,

Ottawa, ON K1S 1N4

CANADA

info@orionbiotechnology.com

+1 343.291.1032